期刊文献+

高超声速弹性飞行器前体压缩性能分析

Analyzing fore-body compression performance of a flexible hypersonic flight vehicle
原文传递
导出
摘要 针对全尺寸的吸气式高超声速飞行器的低阶弹性弯曲模态极易被控制和扰动输入激发的特点,提出了一种基于准定常激波膨胀波理论进行前体处于振动条件下的气流参数计算方法,然后用该方法分析了一个具有二维可调进气道的全尺寸吸气式高超声速飞行器机体弹性弯曲振动对前体压缩性能的影响。分析表明:对于实际飞行中可能发生的小振幅的低频弯曲振动,其最主要的影响是引起头部激波的改变;机体弯曲振动幅值或频率增大都会对超燃冲压发动机进气道调节范围和前体压缩性能产生不利影响。 The control input and disturbance are prone to excite the lower order bending mode of a full-scale airbreathing hypersonic flight vehicle(AHFV).A method based on the quasi-steady shock-expansion wave theory for calculating the unsteady aerodynamics of airframe under bending vibration was proposed for a full-scale AHFV.The effect of airframe bending on the fore-body compression performance is analyzed with this method.It shows that for the possible low frequency and small amplitude vibration of airframe bending,the change of nose shock wave is identified as the main effect;and if the vibration amplitude or frequency of airframe bending is increased,the scramjet may encounter difficulties in adjusting cowl position and compression performance.
出处 《飞行力学》 CSCD 北大核心 2011年第5期57-61,共5页 Flight Dynamics
关键词 吸气式高超声速飞行器 超燃冲压发动机 准定常激波膨胀波理论 压缩性能 airbreathing hypersonic flight vehicle scramjet quasi-steady shock-expansion wave theory compression performance
  • 相关文献

参考文献7

  • 1Sahin U, Tureci O, Chen YT, et al. Expression of multiple cancer/ testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer, 1998, 78: 387 -389.
  • 2Wang Y, Han K J, Pang XW, et al. Large scale identificaion of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol, 2002, 169: 1102-1109.
  • 3Gnjatic S, Atanackovic D, Jager E, et al. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proc Natl Acad Sci USA, 2003, 100:8862 -8867.
  • 4Stockert E, Jager E, Chen YT, et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med, 1998, 187:1349 - 1354.
  • 5Jager E, Gnjatic S, Nagata Y, et al. Induction of primary NY-ESO 1 immunity: CD8 + T lymphocyte and antibody responses in peptide vaccinated patients with NY-ESO-1 + cancers. Proc Natl Acad Sci USA, 2000, 97:12198-12203.
  • 6Marchand M, Punt C J, Aamdal S, et al. Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS 2: a clinical report. Eur J Cancer,2003,39:70-77.
  • 7Kurashige T, Noguchi Y, Saika T, et al. NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res, 2001,61: 4671-4674.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部